Gender Differences in Inflammatory Bowel Disease

doi:10.1159/000504701

Gender Differences in Inflammatory Bowel Disease

2020-01-29

124

OA

AI

DOI：10.1159/000504701

原文链接

查看原文

摘要

En 中文

Immune-mediated diseases typically show a female preponderance. Looking at all autoimmune diseases combined, 8 of 10 patients are females. Although not as prominent, gender differences in inflammatory bowel disease (IBD) have been reported for epidemiology, disease presentation, disease course and complications, medical and surgical therapies, adherence, psychosocial functioning, and psychiatric co-disorders. While for some factors evidence is rather good, for others data are conflicting. Gastroenterologists dealing with IBD patients in daily clinical practice should be aware of gender-specific issues for the following reasons: (1) misperception of disease presentation potentially delays IBD diagnosis, which has been shown to have deleterious effects, and (2) awareness of gender-specific symptoms and disease severity allows initiation of early and adequately tailored treatment. This might prevent development of complications. And (3) insights into gender-specific differences in terms of treatment and adherence to treatment can improve disease management and foster a more individualized treatment approach. In this review, we summarize current knowledge about gender-specific differences in IBD and highlight the most clinically relevant aspects.

Keyword:

Disease activity

Disease course

Disease phenotype

Environmental factors

Epidemiology

Extraintestinal manifestations

Fatigue

Gender

Genetics

Inflammatory bowel disease

Psychological factors

Sex

Gender Differences in Inflammatory Bowel Disease

摘要

AI总结

期刊

机构

引用论文